Michael Hoy, PhD, is currently a Medical Science Liaison at AbbVie, representing the company's anti-infectives portfolio across the northeast U.S. They engage with healthcare providers on bacterial infection treatments and contribute to clinical data discussions for multiple antibiotics. Previously, as a consultant at ClearView Healthcare Partners, they developed strategies for pharma and biotech clients and managed key aspects of project delivery. Michael earned their PhD in Molecular Genetics and Microbiology from Duke University, focusing on antifungal drug development, and holds a Bachelor of Arts in Biology and Environmental Studies from the College of the Holy Cross.
This person is not in the org chart
This person is not in any teams
This person is not in any offices